157 related articles for article (PubMed ID: 29174859)
1. Management of hypogammaglobulinemia and recurrent infections in a chronic lymphocytic leukemia patient receiving ibrutinib.
Jiang F; Verma P
Ann Allergy Asthma Immunol; 2018 Mar; 120(3):324-325. PubMed ID: 29174859
[No Abstract] [Full Text] [Related]
2. [Chronic Lymphocytic Leukemia. New targeted therapy option Ibrutinib].
Bruhn C
Med Monatsschr Pharm; 2014 Jul; 37(7):268-9. PubMed ID: 25065170
[No Abstract] [Full Text] [Related]
3. Spuriously low lymphocyte count associated with pseudoerythroblastemia in a patient with chronic lymphocytic leukemia treated with ibrutinib.
Robier C; Beham-Schmid C; Neubauer M
Clin Chem Lab Med; 2018 Apr; 56(5):e112-e114. PubMed ID: 29252190
[No Abstract] [Full Text] [Related]
4. Chronic lymphocytic leukemia in a patient with well-controlled HIV infection: successful treatment with ibrutinib.
England JT; Leitch HA
Leuk Lymphoma; 2018 Mar; 59(3):752-754. PubMed ID: 28728450
[No Abstract] [Full Text] [Related]
5. Ibrutinib for Chronic Lymphocytic Leukemia.
Ruchlemer R; Ben Ami R; Lachish T
N Engl J Med; 2016 Apr; 374(16):1593-4. PubMed ID: 27096597
[No Abstract] [Full Text] [Related]
6. Ibrutinib for Chronic Lymphocytic Leukemia.
Rigolin GM; Cavazzini F; Cuneo A
N Engl J Med; 2016 Apr; 374(16):1593. PubMed ID: 27096596
[No Abstract] [Full Text] [Related]
7. Ibrutinib for Chronic Lymphocytic Leukemia.
Sharman JP; Mato AR; Keating MJ
N Engl J Med; 2016 Apr; 374(16):1592-3. PubMed ID: 27096595
[No Abstract] [Full Text] [Related]
8. Ibrutinib for Chronic Lymphocytic Leukemia.
Burger JA; Styles L; Kipps TJ
N Engl J Med; 2016 Apr; 374(16):1594-5. PubMed ID: 27096594
[No Abstract] [Full Text] [Related]
9. Ibrutinib in relapsed chronic lymphocytic leukemia.
Neffendorf JE; Gout I; Hildebrand GD
N Engl J Med; 2013 Sep; 369(13):1277. PubMed ID: 24066759
[No Abstract] [Full Text] [Related]
10. Ibrutinib in relapsed chronic lymphocytic leukemia.
Byrd JC; O'Brien S; James DF
N Engl J Med; 2013 Sep; 369(13):1278-9. PubMed ID: 24066758
[No Abstract] [Full Text] [Related]
11. Resolution of eosinophilia and elevated immunoglobulin E with ibrutinib for chronic lymphocytic leukemia.
Harada K; Brooks JP; Lobo FM
Ann Allergy Asthma Immunol; 2018 Nov; 121(5):629-630.e1. PubMed ID: 30009879
[No Abstract] [Full Text] [Related]
12. Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?
Gaye E; Le Bot A; Talarmin JP; Le Calloch R; Belaz S; Dupont M; Tattevin P
Med Mal Infect; 2018 Jun; 48(4):294-297. PubMed ID: 29402474
[No Abstract] [Full Text] [Related]
13. High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.
Teh BW; Chui W; Handunnetti S; Tam C; Worth LJ; Thursky KA; Slavin MA
Leuk Lymphoma; 2019 Jun; 60(6):1572-1575. PubMed ID: 30632838
[No Abstract] [Full Text] [Related]
14. The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands.
van der Straten L; Levin MD; Visser O; Blijlevens NMA; Cornelissen JJ; Doorduijn JK; Kater AP; Dinmohamed AG
Br J Haematol; 2020 Mar; 188(6):e109-e112. PubMed ID: 31991479
[No Abstract] [Full Text] [Related]
15. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Younes A; Brody J; Carpio C; Lopez-Guillermo A; Ben-Yehuda D; Ferhanoglu B; Nagler A; Ozcan M; Avivi I; Bosch F; Caballero Barrigón MD; Hellmann A; Kuss B; Ma DDF; Demirkan F; Yağci M; Horowitz NA; Marlton P; Cordoba R; Wrobel T; Buglio D; Streit M; Hodkinson BP; Schaffer M; Alvarez J; Ceulemans R; Balasubramanian S; de Jong J; Wang SS; Fourneau N; Jurczak W
Lancet Haematol; 2019 Feb; 6(2):e67-e78. PubMed ID: 30642819
[TBL] [Abstract][Full Text] [Related]
16. Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion.
Cavazzini F; Lista E; Quaglia FM; Formigaro L; Cavallari M; Martinelli S; Rigolin GM; Foà R; Cuneo A
Leuk Lymphoma; 2016 Nov; 57(11):2685-8. PubMed ID: 26999572
[No Abstract] [Full Text] [Related]
17. Ibrutinib (Imbruvica) for chronic lymphocytic leukemia.
Med Lett Drugs Ther; 2014 Apr; 56(1440):29-30. PubMed ID: 24736247
[No Abstract] [Full Text] [Related]
18. Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.
Hillmen P; Diels J; Healy N; Iraqi W; Aschan J; Wildgust M
Haematologica; 2018 May; 103(5):e204-e206. PubMed ID: 29419428
[No Abstract] [Full Text] [Related]
19. Ibrutinib increased survival more than chlorambucil in older patients with untreated chronic lymphocytic leukemia.
Aronson FR
Ann Intern Med; 2016 Apr; 164(8):JC44. PubMed ID: 27089094
[No Abstract] [Full Text] [Related]
20. Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib.
Boudin L; Patient M; Tsitsi Nding Tsogou P; Roméo E; Bladé JS; de Jauréguiberry JP
Bull Cancer; 2019 Jan; 106(1):84-85. PubMed ID: 30579570
[No Abstract] [Full Text] [Related]
[Next] [New Search]